Beryl Drugs Limited (BOM:524606)
India flag India · Delayed Price · Currency is INR
20.35
+1.73 (9.29%)
At close: Mar 10, 2026

Beryl Drugs Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Market Capitalization
103107149625334
Upgrade
Market Cap Growth
-38.63%-28.23%141.20%16.36%58.09%81.10%
Upgrade
Enterprise Value
1461501941068572
Upgrade
Last Close Price
20.3521.0529.3312.1610.456.61
Upgrade
PE Ratio
731.9818.4519.358.05-13.99
Upgrade
PS Ratio
0.580.510.560.230.360.24
Upgrade
PB Ratio
1.091.121.670.770.730.42
Upgrade
P/TBV Ratio
1.091.121.670.770.730.42
Upgrade
P/FCF Ratio
-23.65-7.45--
Upgrade
P/OCF Ratio
-4.0518.142.58-9.90
Upgrade
EV/Sales Ratio
0.820.710.730.400.580.51
Upgrade
EV/EBITDA Ratio
10.135.737.344.7715.354.43
Upgrade
EV/EBIT Ratio
92.3010.9113.437.52-20.77
Upgrade
EV/FCF Ratio
-33.29-12.81--
Upgrade
Debt / Equity Ratio
0.450.430.570.560.730.65
Upgrade
Debt / EBITDA Ratio
2.991.561.932.049.603.17
Upgrade
Debt / FCF Ratio
-9.08-5.49--
Upgrade
Net Debt / Equity Ratio
0.450.350.560.490.630.56
Upgrade
Net Debt / EBITDA Ratio
2.951.251.881.788.382.76
Upgrade
Net Debt / FCF Ratio
-7.28-9.354.80-5.23-3.35
Upgrade
Asset Turnover
-1.261.531.520.800.79
Upgrade
Inventory Turnover
-5.739.727.243.274.44
Upgrade
Quick Ratio
-1.471.341.250.790.85
Upgrade
Current Ratio
-2.101.761.641.241.24
Upgrade
Return on Equity (ROE)
-6.28%9.05%9.97%-8.66%3.08%
Upgrade
Return on Assets (ROA)
-5.15%5.16%4.99%-1.83%1.21%
Upgrade
Return on Invested Capital (ROIC)
1.15%6.90%8.48%9.17%-4.40%1.92%
Upgrade
Return on Capital Employed (ROCE)
-11.80%12.30%12.60%-5.70%3.30%
Upgrade
Earnings Yield
0.14%5.42%5.17%12.42%-12.43%7.15%
Upgrade
FCF Yield
-4.23%-3.57%13.42%-16.68%-39.77%
Upgrade
Buyback Yield / Dilution
-0.08%---0.01%-0.01%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.